Andy, 35, was already aware of his vision problems. He had been diagnosed with a genetic condition called retinal dystrophy ...

Alani Ferreira may have lost count of how many times she has won the disabled race at the aQuellé Midmar Mile, but the three-time Paralympian was no less thrilled to cross the finish line first once ...

A man had a shocking realization about his health after he kept putting his son in mismatched shoes — his genetic vision condition was getting worse. Andy Johnson, 35, and his family have since ...

Andy, who has retinal dystrophy, initially had avoidance anxiety and "wouldn't cross a road, wouldn't take the kids to school ...

Police say the men are due to appear in court charged with the murder of Ian Jackson-Wynch. Andy, who has retinal dystrophy, initially had avoidance anxiety and "wouldn't cross a road, wouldn't take ...

Detailed price information for Entrada Therapeutics Inc (TRDA-Q) from The Globe and Mail including charting and trades.

Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced ...

At the end of 2025, Opus Genetics completed a Type B Regenerative Medicine Advanced Therapy (RMAT) meeting with the US Food and Drug Administration (FDA) regarding OPGx-LCA5, its gene therapy ...

A coronial inquest will investigate why three doctors failed to alert relevant authorities that a man was unfit to drive due to vision impairment in the years before he caused a crash which killed a ...

Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...